Candriam SCA’s Keros Therapeutics KROS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
|
|||||
|
2024
Q3 | $20.1M | Sell |
|
|||||
|
2024
Q2 | $20.2M | Sell |
|
|||||
|
2024
Q1 | $43.2M | Sell |
|
|||||
|
2023
Q4 | $32.6M | Buy |
|
|||||
|
2023
Q3 | $23.6M | Buy |
|
|||||
|
2023
Q2 | $29M | Sell |
|
|||||
|
2023
Q1 | $29.3M | Buy |
|
|||||
|
2022
Q4 | $30.1M | Buy |
|
|||||
|
2022
Q3 | $13.6M | Hold |
|
|||||
|
2022
Q2 | $9.99M | Sell |
|
|||||
|
2022
Q1 | $22.9M | Buy |
|
|||||
|
2021
Q4 | $14.1M | Hold |
|
|||||
|
2021
Q3 | $9.53M | Buy |
|
|||||
|
2021
Q2 | $4.31M | Buy |
|